2015
DOI: 10.1038/ki.2015.61
|View full text |Cite
|
Sign up to set email alerts
|

The growth of acute kidney injury: Eastern European perspective

Abstract: buffer capacity of the kidney is exceeded. 2 We suggest that in aPLA2R-negative patients PLA2R-related disease must be excluded either by staining of PLA2R in kidney biopsies or by renewed evaluation of serum after 6-month follow-up. 1. Debiec H, Ronco P. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med 2011; 364: 689-690. 2. Fresquet M, Jowitt TA, Gummadova J et al. Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 3 publications
0
4
0
Order By: Relevance
“…Yet few studies have previously addressed the incidence rate of dialysis-requiring AKI in general populations. Published incidence rates suggest persistent increase with recent annual growth >10% [ 2 , 6 , 22 25 ]. However, updated and comprehensive information is limited, and major publications have predominantly been based on data from the US.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Yet few studies have previously addressed the incidence rate of dialysis-requiring AKI in general populations. Published incidence rates suggest persistent increase with recent annual growth >10% [ 2 , 6 , 22 25 ]. However, updated and comprehensive information is limited, and major publications have predominantly been based on data from the US.…”
Section: Discussionmentioning
confidence: 99%
“…Acute kidney injury (AKI) continues to be a critical illness with profound effects on patient outcomes [ 1 ]. Prior epidemiologic studies on AKI have predominantly focused on incidence and outcome measures [ 2 6 ], and in spite of reported prevalences >20% amongst hospitalized adults [ 7 ], research on comorbid predisposition, and particularly concomitant medication, is sparse. Additionally, identification and management of AKI–and particularly dialysis-requirement–is characterized by regional and national disparities partly due to differing availability of treatment resources; such disparity makes comparison difficult [ 8 , 9 ].…”
Section: Introductionmentioning
confidence: 99%
“…Continuous renal replacement therapy (CRRT) is the most commonly selected modality of renal replacement therapy for the dialysis required for acute kidney injury (AKI) patients in the intensive care unit (ICU) [ 1 , 2 ]. Globally, the requirement of CRRT is increasing with the growing incidence of AKI [ 3 5 ]. According to a nationwide study conducted in Denmark [ 5 ], the crude incidence of AKI requiring dialysis increased from 143 per million in 2000 to 360 per million in 2012.…”
Section: Introductionmentioning
confidence: 99%
“…
A cute kidney injury (AKI) is increasingly common in the hospitalized patient 1,2 with recent adult and pediatric multinational studies reporting AKI rates of 57% and 27%, respectively. 3,4 The development of AKI is associated with significant adverse outcomes including an increased risk of mortality.
…”
mentioning
confidence: 99%